Xencor Shifts Focus at 12th Annual Cantor Fitzgerald Healthcare Conference

Xencor announced a strategic shift during the 12th Annual Cantor Fitzgerald Global Healthcare Conference. The company is moving its focus toward late-stage development projects. This change aims to enhance its position in the healthcare market with more advanced therapeutic options. Such strategic shifts can have significant implications for investor confidence and market performance, which is an important factor to consider for those looking at Xencor (XNCR).